On Air Now

Listen

Listen Live Now » 101.9 FM Central Wisconsin

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
66° Feels Like: 66°
Wind: SE 8 mph Past 24 hrs - Precip: 0.17”
Current Radar for Zip

Today

Thunderstorms 76°

Tonight

Thunderstorms 66°

Tomorrow

AM Clouds/PM Sun 82°

Alerts

Another Supernus epilepsy drug gets FDA nod

(Reuters) - Supernus Pharmaceuticals Inc's experimental epilepsy drug Oxtellar XR won marketing approval from the U.S. Food and Drug Administration, the second drug approval for the company since it went public in May.

Oxtellar XR's final marketing approval follows the tentative approval given in late-June to Supernus's Trokendi XR -- a generic epilepsy treatment.

The company plans to launch Oxtellar in the first quarter of 2013.

Rockville, Maryland-based Supernus is developing several other drugs for epilepsy, depression and attention deficit hyperactivity disorder.

Supernus's shares closed at $12.97 on Friday on the Nasdaq.

(Reporting By Pallavi Ail in Bangalore; Editing by Supriya Kurane)

Comments